United Kingdom next generation sequencing market is expected to register robust growth in the forecast period, 2023-2027.
Rise in Genome Mapping Programs is Projected to Catalyze the Market Growth
The decreasing cost of sequencing has allowed governments bodies across United Kingdom to involve genomic analysis as a significant part of disease diagnosis and personalized medicine. Various public genome research initiatives have been undertaken and enhancing focus on genomics health futures mission for the improvement of research & development activities. The extensive investments on R & D activities to expand access to new research capabilities, clinical trials, and technologies for betterment of healthcare sector which is acting as another growth-inducing factor. The increase in genome mapping programs and extensive research activities on personalized medicine has further augmented the
Extensive R&D activities for Developing Novel Next Generation Sequencing Technologies Fuels the Market Growth
The rising R&D activities for producing therapies used in the treatment of genetic disorders will inflate the need for next generation sequencing procedure over the analysis period. With this, the elevating investments in R&D activities and high number of studies related to treatment of genetic disorders among individuals is going to support the growth of the market. Government bodies of developed economies such as United Kingdom have launched numerous policies and initiated acts for encouraging scientists and researchers to find solutions for treating chronic and rare ailments. All these aforementioned factors are expected to drive the market towards growth over the forecast period.
Escalating Demand for DNA Testing is Estimated to Witness the Market Growth
The growing demand for DNA testing owing to the continuous advancements in whole genome and exome sequencing procedures, which offers faster results and cost effectives of the process as compared to genotyping-based DNA microarray. This made manufacturers to launch the first commercial sequencer, MinIon, utilizing Nanopore technology was launched by Oxford Nanopore Technologies. The sequencer assists in identifying DNA by measuring the modifications in the electrical conductivity generated DNA strands passed through biological pore. This technology allowed the detection of outbreaks such as Zika virus. Various organizations worked on DNA sequencing technologies for applied genomic testing, by introducing GENIUS sequencer, which can sequence DNA anywhere.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The United Kingdom next generation sequencing market is segmented
Market Players
Thermo Fischer Scientific, Inc., Illumina Cambridge Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited, are the significant market players operating in United Kingdom next generation sequencing market.
Attribute | Details |
Base Year | 2021 |
Historic Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Product · Technology · Application · End User |
Regional scope | London, Southeast, East Anglia, Scotland, Southwest, East Midlands, and Yorkshire & Humberside |
Key companies profiled | Thermo Fischer Scientific, Inc., Illumina Cambridge Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited |
Customization scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |